The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.

The object of this study was to establish the association between the metabolic syndrome and oxidized LDL (oxLDL) and to determine the risk for coronary heart disease (CHD) in relation to the metabolic syndrome and levels of oxLDL. OxLDL was measured in plasma from 3,033 elderly participants in the Health, Aging, and Body Composition study. The metabolic syndrome was defined according to criteria established in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. We observed that the metabolic syndrome was associated with higher levels of oxLDL due to a higher fraction of oxLDL, not to higher levels of LDL cholesterol. Individuals with the metabolic syndrome had twice the odds of having high oxLDL (>1.90 mg/dl) compared with those not having the metabolic syndrome, after adjusting for age, sex, ethnicity, smoking status, and LDL cholesterol. Among those participants who had the metabolic syndrome at study entry, incidence rates of future CHD events were 1.6-fold higher, after adjusting for age, sex, ethnicity, and smoking status. OxLDL was not an independent predictor of total CHD risk. However, those with high oxLDL showed a greater disposition to myocardial infarction (relative risk 2.25, 95% confidence interval 1.22-4.15). We concluded that the metabolic syndrome, a risk factor for CHD, is associated with higher levels of circulating oxLDL that are associated with a greater disposition to atherothrombotic coronary disease.

[1]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[2]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[3]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[4]  D. Shih,et al.  HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Collen,et al.  Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Shepherd.  Issues surrounding age: vascular disease in the elderly , 2001, Current opinion in lipidology.

[7]  M. Sampson,et al.  Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[8]  F. Werf,et al.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.

[9]  M. Taskinen,et al.  Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. , 1999, Diabetes care.

[10]  S. Rubin,et al.  Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. Couturier,et al.  Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[12]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[13]  Joseph L. Goldstein,et al.  The Cholesterol Quartet , 2001, Science.

[14]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[15]  J. Berliner,et al.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.

[16]  J. Sasaki,et al.  In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. , 2000, Atherosclerosis.

[17]  E. Bourdon,et al.  Glucose and free radicals impair the antioxidant properties of serum albumin , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[19]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[20]  S. Dymarkowski,et al.  Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. , 2002, Cardiovascular research.

[21]  J. Goodwin,et al.  Spectrophotometry of proline in plasma and urine. , 1972, Clinical chemistry.

[22]  R. Langer,et al.  Metabolic syndrome and ischemic heart disease in elderly men and women. , 2001, American journal of epidemiology.

[23]  F. Van de Werf,et al.  Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Kurabayashi,et al.  Circulating Oxidized Low Density Lipoprotein Levels: A Biochemical Risk Marker for Coronary Heart Disease , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  S. Halimi,et al.  Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. , 2000, Diabetes care.

[27]  M. Hanefeld,et al.  In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. , 2002, Diabetes.

[28]  D. Stengel,et al.  Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis , 2003, Circulation.

[29]  E. Lesaffre,et al.  Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure , 1996, Thrombosis and Haemostasis.

[30]  G. Reaven,et al.  The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers. , 2000, Atherosclerosis.

[31]  C. Napoli,et al.  Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. , 2001, European heart journal.

[32]  M. Brown,et al.  Molecular medicine. The cholesterol quartet. , 2001, Science.

[33]  BjörnFagerberg,et al.  Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) , 2002 .

[34]  T. Forte,et al.  Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity. , 1999, Journal of lipid research.

[35]  T. Matsuo,et al.  Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.

[36]  M. Trevisan,et al.  Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. , 1998, American journal of epidemiology.

[37]  B. Fagerberg,et al.  Circulating oxidized low‐density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58‐year‐old men (AIR study) , 2002, Journal of internal medicine.

[38]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[39]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[40]  B. Fagerberg,et al.  Circulating oxidized LDL is associated with increased levels of cell-adhesion molecules in clinically healthy 58-year old men (AIR study). , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[41]  D. Collen,et al.  Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[42]  Nancy R Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[43]  M. Maekawa,et al.  Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes. , 2002, Journal of atherosclerosis and thrombosis.

[44]  PaulHolvoet,et al.  LDL Hypercholesterolemia Is Associated With Accumulation of Oxidized LDL, Atherosclerotic Plaque Growth, and Compensatory Vessel Enlargement in Coronary Arteries of Miniature Pigs , 1998 .

[45]  P. Holvoet,et al.  Oxidized LDL and HDL: antagonists in atherothrombosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.